AAAAAA

   
Results: 1-8 |
Results: 8
Heterozygous HESX1 mutations associated with isolated congenital pituitaryhypoplasia and septo-optic dysplasia
Authors: Thomas, PQ Dattani, MT Brickman, JM McNay, D Warne, G Zacharin, M Cameron, F Hurst, J Woods, K Dunger, D Stanhope, R Forrest, S Robinson, ICAF Beddington, RSP
Citation: Pq. Thomas et al., Heterozygous HESX1 mutations associated with isolated congenital pituitaryhypoplasia and septo-optic dysplasia, HUM MOL GEN, 10(1), 2001, pp. 39-45
An open-label acceptability study of Norditropin SimpleXx - A new liquid growth hormone formulation
Authors: Stanhope, R Buchanan, C Butler, G Costigan, C Dunger, D Greene, S Hoey, H Hughes, I Kelnar, C Kirk, J Komulainen, J Lowry, M Warner, J
Citation: R. Stanhope et al., An open-label acceptability study of Norditropin SimpleXx - A new liquid growth hormone formulation, J PED END M, 14(6), 2001, pp. 735-740
Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight
Authors: Michelmore, K Ong, K Mason, S Bennett, S Perry, L Vessey, M Balen, A Dunger, D
Citation: K. Michelmore et al., Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight, CLIN ENDOCR, 55(4), 2001, pp. 439-446
A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis
Authors: Johnston, DI Betts, P Dunger, D Barnes, N Swift, PGF Buckler, JMH Butler, GE
Citation: Di. Johnston et al., A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis, ARCH DIS CH, 84(1), 2001, pp. 76-80
Precocious pubarche in girls and the development of androgen excess
Authors: Ibanez, L Potau, N Dunger, D de Zegher, F
Citation: L. Ibanez et al., Precocious pubarche in girls and the development of androgen excess, J PED END M, 13, 2000, pp. 1261-1263
Size at birth and cord blood levels of insulin, insulin-like growth factorI (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants
Authors: Ong, K Kratzsch, J Kiess, W Costello, M Scott, C Dunger, D
Citation: K. Ong et al., Size at birth and cord blood levels of insulin, insulin-like growth factorI (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants, J CLIN END, 85(11), 2000, pp. 4266-4269
Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes
Authors: Casteels, K Ong, K Phillips, D Bendall, H Pembrey, M Poulton, J Dunger, D
Citation: K. Casteels et al., Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes, LANCET, 353(9163), 1999, pp. 1499-1500
The 5 '-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian Type I diabetic patients
Authors: Dyer, PH Chowdhury, TA Dronsfield, MJ Dunger, D Barnett, AH Bain, SC
Citation: Ph. Dyer et al., The 5 '-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian Type I diabetic patients, DIABETOLOG, 42(8), 1999, pp. 1030-1031
Risultati: 1-8 |